Navigation Links
Inspire's Phase 3 CF Trial, Using PARI's Nebulizer & Compressor, Shows Positive Top-Line Results
Date:6/12/2008

MIDLOTHIAN, Va., June 12 /PRNewswire/ -- On Friday, Inspire Pharmaceuticals (Nasdaq: ISPH) announced positive top-line results of the first Phase 3 trial with denufosol tetrasodium inhalation solution delivered via PARI's LC STAR nebulizer and PRONEB Ultra compressor for the treatment of cystic fibrosis (CF).

"We are pleased to see these positive top-line results and hope that Inspire's denufosol tetrasodium inhalation solution delivered via PARI's LC STAR and PRONEB Ultra compressor will become the first early intervention therapy available to CF patients," said Lisa Cambridge, director of Clinical Development at PARI Respiratory Equipment.

The trial demonstrated statistical significance for its primary efficacy endpoint, which was the change in FEV1 (Forced Expiratory Volume in One Second) from baseline at the trial endpoint (at 24 weeks or last observation carried forward). Patients treated with denufosol had a statistically significant improvement in FEV1 compared to placebo (45 milliliter treatment group difference, p = 0.047). On average, patients on denufosol improved relative to baseline whereas patients on placebo remained essentially unchanged.

The results were reported from the 24-week placebo-controlled portion of the 352-patient Phase 3 trial (TIGER-1) with denufosol tetrasodium inhalation solution for the treatment of cystic fibrosis. Additional information is available at http://www.inspirepharm.com.

The combination of PARI's LC STAR breath-enhanced nebulizer and PRONEB Ultra compressor provides for a quick treatment with high efficiency and minimal medication waste.

Denufosol for the treatment of cystic fibrosis has been granted Fast
'/>"/>

SOURCE PARI Respiratory Equipment, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine technology :

1. Positive Phase I/II Data of IDX899 Confirm Potent Antiviral Activity and Favorable Safety Profile in Treatment-Naive HIV-Infected Patients
2. Arena Pharmaceuticals Presented Positive Phase 2a Clinical Trial Results of APD125 for the Treatment of Insomnia at 22nd Annual Meeting of the Associated Professional Sleep Societies
3. ChemoCentryx Completes Enrollment of PROTECT-1, a Phase II/III Clinical Trial of CCR9 Antagonist CCX282-B (Traficet-EN(TM)) in Crohns Disease
4. Repligen Announces Plans to Initiate a Phase 2b Trial for RG2417 in Bipolar Disorder
5. Micromet and MedImmune Commence Treatment in Phase 2 Trial of BiTE Antibody Blinatumomab (MT103/MEDI-538) in Patients with Acute Lymphoblastic Leukemia
6. Vical Receives $6.3 Million Payment for Continued Funding of Allovectin-7(R) Phase 3 Trial
7. Targeted Genetics Announces Positive Phase 1/2 tgAAC94 Data Presented at Annual European Congress of Rheumatology
8. Iomai Announces Publication in The Lancet of Phase II Study Demonstrating Significant Efficacy of Travelers Diarrhea Vaccine
9. Morria Biopharmaceuticals Plc Announces Regulatory Approval to Commence Phase II Clinical Study of MRX-4 in Allergic Rhinitis
10. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Melanoma
11. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/20/2009)... , , MEMPHIS, Tenn., Nov. 20 /PRNewswire-...rthopaedics Division is pleased to announce the si...e United States Department of Defense that may lea...tended to revolutionize the treatment of the limbs..., Last year, the Defense Advanced Research Projec...
(Date:11/19/2009)... , , LYON, France, Nov. 19 ...tes supplying dangerous and illegal medicines, Ope...dinated by INTERPOL and the World Health Organizat...eiting Taskforce (IMPACT) to highlight the dangers...lobal initiative resulted in a series of arrests a...
(Date:11/19/2009)... , , DAYTON, Ohio, Nov. 19 ...will be partnering with leading Canadian medical i...w Enhanced Chest Imaging and OnGuard Chest Xray CA... based Riverain Medical,s products to the Canadian...eputable sales channel. ,, SoftView Enhanced Ch...
Breaking Medicine Technology:Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 2Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 3Smith & Nephew Orthopaedics Selected to Develop New Technology for Treating Battlefield Injuries 4International Operation Combats Online Supply of Counterfeit and Illegal Medicines 2Riverain Medical Partners With The Christie Group In Canada To Offer SoftView Enhanced Chest Imaging and OnGuard Chest X-Ray CAD Technologies 2Emerging Woman Business Owner of the Year Winner Offers 5 Tips to New Women Business Owners 52074 1Emerging Woman Business Owner of the Year Winner Offers 5 Tips to New Women Business Owners 52074 2OpenQ Posts a 200 25 Revenue Growth in the First Half of 2009 13081 1OpenQ Posts a 200 25 Revenue Growth in the First Half of 2009 13081 2Interaction Associates and The Interaction Institute for Social Change Present at the Greater Than Conference 52071 1Interaction Associates and The Interaction Institute for Social Change Present at the Greater Than Conference 52071 2Interaction Associates and The Interaction Institute for Social Change Present at the Greater Than Conference 52071 3
...Pa. and LYON, France, Aug. 1 Sanofi,Pasteur, the ...hipping,influenza vaccine (Fluzone(R), Influenza V...09 season. The first 1.3 million doses of influenz...ting clearance of the,2008-2009 formulation by the...4, 2008., Vaccine shipments to health-care provid...
...me First Effective Drug for Rare Genetic Disorder ... have used,a drug to achieve normal levels of bloo...abnormally high insulin levels. If this approach,s...edicine for children,with congenital hyperinsulini...ease in which insulin levels become dangerously hi...
Other Medicine Technology:Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 2Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 3Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 4Sanofi Pasteur Shipping First Doses of Influenza Vaccine for the 2008-2009 Season in the US 5Treatment Corrects Severe Insulin Imbalance in Animal Studies 2Treatment Corrects Severe Insulin Imbalance in Animal Studies 3
(Date:11/21/2009)... Linwood Group ask whether there is a secre...d? , London, UK (PRWEB) N... up to one in three of the adult UK population dri...g alcohol-related liver disease*, it is hardly a s...bilitation programmes and residential centres for ...
(Date:11/20/2009)... Mass., Nov. 20 Following a recall...ny removed from sale Shedd,s Country Crock ® ...,s Country Crock ® Side Dishes DELUXE Four Ch... ,, The following code dates and UPCs are affec...es DELUXE Cheddar Broccoli Rice 21 oz, UPC 0274002...
(Date:11/20/2009)...HAIFA, Israel, November 20 /PRNewswire-FirstCall/ ... http://www.CVSLMEDICAL.COM , a leading,developer...day announced that,the company,s Board of Director...urope, Canada and the Far East for its proprietary...for all angioplasty (PCTA) procedures. , ...
(Date:11/20/2009)...f exposure to formaldehyde used for embalming in t...sed risk of death from myeloid leukemia, according...e Journal of the National Cancer Institute . , ...lymphohematopoietic malignancies and brain cancer ...workers, all of whom may have worked with formalde...
(Date:11/20/2009)...to one-third buying 90-day supply, study finds , ...ing a three-month supply of prescription drugs is ...pply, according to a new study. , U.S. research...rugs between 2000 and 2005, and found that patient...-month supply saved an average 29 percent in out-o...
Breaking Medicine News(10 mins):Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 2Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 3Health News:Linwood Group Reveal How to Decide whether Alcohol Rehab Centres are a Success or Not 4Health News:Stop & Shop Alerts Customers to Voluntary Recall by Unilever 2Health News:Cardio Vascular Medical Device to Apply for Additional Patents in Europe, Canada and Far East 2Health News:Funeral industry workers exposed to formaldehyde face higher risk of leukemia 2Health News:Three-Month Supply Lowers Drug Costs 2
...g islands in the Indian Ocean such as Mauritius ha...s, which has claimed 77 lives so far, according to... is characterized by fever, joint and muscle pain,...ersity of Lausanne, Switzerland have reported the ...
...0 people in the U.S. are suffering from long-term ...currences taking place each year//. One stud...of Neuroscience appears to be on the right track t...ld be a return of functional activity. John ...
...ern South Africa turn to nature when seeking to ac...a, it emerged in news reports//. The root of ...ound in the villages of the Venda district near th...ther traditional drinks has been shown to relax th...
...to measure the presence and severity of involuntar...kinson's disease is being developed// and a couple... Michael J. Fox Foundation for this purpose. ...oetz, Director of Movement Disorders of Rush Unive...
...alone are twice as likely to have serious heart pr...w study//. According to a study published in ...Danish researchers surveyed around 1,38,000 adults... people who live alone. Doctors in India bel...
...oddlers should not be blamed on family environment...ays a study// that would come as a reassurance to ...ethon Institute for Child Health Research in Austr.... The studied children were from infancy to ...
Other Medicine News:Health News:New Method For Measuring Dyskinesia In Parkinson's Being Developed 2Health News:Toddlers' Delayed Speech not Due to Parenting Faults 2
Stat Profile® pHOx® CO-Oximeter
ACCU-DISC™ Pressure Monitoring System
...d-through motion and low perfusion pulse oximetry,...kthrough designs, including sensors with built-in ... that automatically tells the oximeter which monit...ensors made specifically for the patients they are...
ImmunoWELL Mumps Virus IgG Test
Medicine Products: